胫后动脉皮支为蒂的逆行岛状皮瓣修复足部软组织缺损

目的　探讨以胫后动脉皮支为蒂的逆行岛状皮瓣修复足部软组织缺损的临床应用效果和有关问题。方法　应用胫后动脉皮支为蒂的逆行岛状皮瓣修复足部软组织缺损。缺损面积为 3cm× 4cm～ 8cm× 12cm。设计的皮瓣面积为 4cm× 8cm～ 10cm× 13cm。结果　 6例患者皮瓣全部成活 ,创面Ⅰ期愈合 ,1例患者皮瓣远端小部分坏死 ,经换药处理后 ,创面Ⅱ期愈合 ,术后随访患者 6～ 2 4个月 ,均取得满意效果。结论　胫后动脉皮支为蒂的逆行岛状皮瓣血供充分 ,蒂长 ,皮瓣切取面积大 ,是修复足部软组织缺损的理想皮瓣     

逆行胫前动脉岛状皮瓣修复足部皮肤软组织缺损

目的探讨应用带蒂逆行胫前动脉皮支岛状皮瓣修复足部皮肤软组织缺损的疗效。方法2000年7月～2005年4月,收治10例各种原因致足部皮肤软组织缺损,均存在不同程度的骨、关节与肌腱外露,软组织缺损范围6cm×4cm～16cm×10cm。急诊修复7例;择期手术3例,其中1例足部黑色素瘤7年伴皮肤破溃5个月,行手术扩大切除。应用带蒂的胫前动脉皮支岛状皮瓣逆行移位修复,皮瓣切取范围8cm×5cm～17cm×12cm。结果术后皮瓣均成活,创口期愈合。随访1～21个月,皮瓣外观好,不臃肿,无感染、破溃。足部外形满意,行走正常,皮肤两点辨别觉1.0～2.5cm。结论胫前动脉皮支皮瓣血管解剖恒定,易于解剖,皮瓣可切取面积大,手术方法简便,成功率高,适用于足部皮肤软组织缺损的修复。     

皮神经伴行血管蒂逆行岛状皮瓣的临床应用

目的 :探讨皮神经伴行血管蒂逆行岛状皮瓣的临床应用。方法 :使用前臂外侧皮神经伴行血管蒂逆行岛状皮瓣修复腕掌、腕背及虎口部皮肤软组织缺损 5例。腓肠神经伴行血管蒂逆行岛状皮瓣修复小腿远端、足跟足背皮肤软组织缺损 10例。皮瓣切取面积 5 cm× 5 cm～ 15 cm× 9cm。结果 :15例皮瓣 ,13例完全成活。1例皮瓣远端边缘 0 .5 cm坏死 ,经换药后愈合。 1例皮瓣坏死 ,创面植皮后愈合。结论 :皮神经伴行血管蒂逆行岛状皮瓣血供可靠 ,切取简便、安全 ,不牺牲主要血管 ,是修复四肢皮肤软组织缺损较好的方法之一     

第1跖背动脉逆行足背皮瓣修复足远端创面

目的　探索一种能修复足部远端创面的新手术方法。方法　设计以足背动脉的第 1跖背动脉为血管蒂的逆行岛状皮瓣 ,转移至足部远端创面。结果　临床治疗 5例患者 ,皮瓣面积为2cm× 4cm～ 6cm× 7cm。除 1例皮瓣远端表皮坏死外 ,其余成活良好 ,外形矫正满意 ,术后 1～ 2个月后行走恢复良好。结论　以足背动脉的第 1跖背动脉为血管蒂的逆行岛状皮瓣具有良好的血运 ,血管解剖比较恒定 ,操作简便 ,是修复足部远端创面的可取方法     

带蒂皮瓣治疗小腿和足踝部皮肤软组织缺损

目的探讨小腿和足踝部皮肤软组织缺损的手术方法及其疗效评价。方法1997年6月至2005年12月,43例小腿及足踝部皮肤软组织缺损的患者,男38例,女5例;年龄7～63岁,平均35岁;皮瓣面积4cm×3cm～25cm×15cm。采用9种带蒂的肌皮瓣和筋膜皮瓣进行治疗:(1)腓肠肌内、外侧头肌皮瓣带蒂转移修复小腿中上1/3合并膝关节前及内侧皮肤软组织缺损2例;(2)小腿前内侧交腿皮瓣修复小腿中段胫前皮肤软组织缺损2例;(3)带隐神经小腿内侧交腿皮瓣修复前足足底缺损1例;(4)带胫后动脉小腿内侧逆行岛状皮瓣修复足背部皮肤软组织缺损1例;(5)小腿内侧远端蒂筋膜皮瓣修复小腿中下1/3胫前皮肤软组织缺损2例;(6)腓肠神经营养血管蒂逆行岛状皮瓣修复小腿中下1/3、踝部及足跟皮肤软组织缺损17例;(7)隐神经营养血管蒂逆行岛状皮瓣修复小腿中下1/3、踝部及足背皮肤软组织缺损14例;(8)外踝上动脉逆行岛状皮瓣修复足背皮肤软组织缺损2例。(9)足内侧远端带蒂岛状筋膜皮瓣修复第一跖骨头处皮肤软组织缺损2例。结果43例皮瓣中有37例术后全部成活,创面一期愈合,1例皮瓣浅层坏死,5例皮瓣远端边缘少许坏死,经短期换药后愈合。所有病例均得到随访,皮瓣全部良好。结论治疗小腿和足踝部皮肤软组织缺损应严格掌握手术适应证,合理选择皮瓣种类。腓肠神经和隐神经营养血管蒂岛状皮瓣是较理想的修复小腿及足踝部软组织缺损的材料。     

足跟部皮肤软组织缺损的皮瓣修复

目的　总结应用多种轴型岛状皮瓣修复足跟部皮肤软组织缺损的效果。方法　采用足底内侧岛状皮瓣、胫后动脉逆行岛状皮瓣转移或“桥式”交腿移位、逆行腓肠神经营养血管岛状皮瓣、足中段邻近皮瓣等形式 ,修复足跟部皮肤软组织缺损 14例。皮瓣切取范围 5cm× 5cm～ 16cm× 10cm。结果　皮瓣全部成活 ,未发生血管危象 ,创面Ⅰ期愈合。随访 6个月～ 11年 2个月 ,14例外观功能均恢复良好 ,皮肤质地接近正常 ,负重后无溃疡和骨髓炎复发。结论　足跟部为负重区 ,对皮肤软组织缺损修复要求较高 ,以质地接近的轴型皮瓣或逆行岛状皮瓣修复效果较好     

以踝部吻合支供血的胫前动脉逆行岛状皮瓣的临床应用

目的探讨为足背部皮肤及软组织缺损进行修复提供一种新型血供来源的皮瓣。方法根据下肢胫前动脉及足背动脉的行径、分支、分布及其与胫后动脉、腓动脉分支的吻合情况,设计以踝部吻合支供血的胫前动脉逆行岛状皮瓣,临床应用修复足背皮肤及软组织缺损11例,皮瓣面积最大13cm×9cm,最小8cm×6cm。结果胫前动脉及足背动脉在踝部的4个分支（外踝前动脉、内踝前动脉、跗外侧动脉、跗内侧动脉）经与腓动脉及胫后动脉的分支吻合,可以满足胫前动脉逆行岛状皮瓣的供血需要。临床应用中,10例皮瓣全部存活,1例皮瓣有远侧小部分坏死,经换药及游离植皮后创面愈合。结论以踝部吻合支供血的胫前动脉逆行岛状皮瓣转移可用于修复足背部的皮肤及软组织缺损。     

内踝上肌间隙穿支逆行岛状皮瓣的临床应用

目的 探讨内踝上肌间隙穿支逆行岛状皮瓣修复胫前、足、踝部创面的临床效果.方法 我们通过对12例胫前皮肤软组织缺损、3例踝部皮肤软组织缺损、5例足部皮肤软组织缺损采用同侧及对侧胫后动脉内踝上肌间隙穿支逆行岛状皮瓣修复.结果 临床应用20块皮瓣,皮瓣大小为18 cm×9 cm～11 cm×6 cm,筋膜蒂宽4～6 cm,皮瓣全部成活.10例术后随访3～6个月,皮瓣色泽、质地、外形均良好.结论 内踝上肌间隙穿支逆行岛状皮瓣血运可靠,不牺牲主要血管,皮瓣修复范围广,皮瓣厚薄适中,质地好,手术简单安全,是修复胫前、足跟、内踝部创面的理想皮瓣.     

腓肠神经营养血管蒂逆行岛状皮瓣修复足部软组织缺损

目的　观察应用腓肠神经营养血管蒂逆行岛状皮瓣修复足部软组织缺损的临床效果。方法　对 1 8例足部软组织缺损患者 ,以其腓肠神经营养血管为蒂 ,于小腿后侧切取皮瓣逆行转移修复缺损区。观察术后患者皮瓣成活情况及供区创面愈合情况。　结果　术后皮瓣均成活 ,切取的最大皮瓣为 1 0 .5cm× 1 6.5cm。供区创面愈合良好 ,除外观略受影响外活动功能基本正常。　结论　腓肠神经营养血管蒂逆行岛状皮瓣切取简便 ,移植成活率高 ,是修复足部软组织缺损的较好方法。     

足底深支或(和)第一跖背动脉逆行足背岛状皮瓣的临床应用

目的探索足部远端软组织缺损修复的较佳方法。方法采用足底深支或(和)第1跖背动脉逆行足背岛状皮瓣对6例足部远端软组织缺损创面进行修复。结果6例患者均一次性修复,软组织缺损最大面积8cm×6cm,术后随访1~4年,足部功能与外观均较满意。结论足底深支或(和)第1跖背动脉逆行足背岛状皮瓣血管解剖比较恒定,操作简单,是修复足远端软组织缺损的较好方法。     

Clinical experience with duodenum-preserving total resection of the head of the pancreas with pancreaticocholedochoduodenostomy

The results of duodenum-preserving total resection of the head of the pancreas (DpTRHP) in 20 patients were compared with the results of pylorus-preserving pancreatico-duodenostomy (PpPD), a procedure in conventional use for the treatment of benign diseases, in 19 patients. The mean operative time for DpTRHP was 4.5±0.9 h, this being not significantly different from that for PpPD, whereas the mean intraoperative blood loss with DpTRHP (825±508ml) was significantly less than that with PpPD (1382±798 ml) (P<0.05). The morbidity and mortality rates of patients treated with DpTRHP were 25% and 0%, respectively, and there were no significant differences between the two surgical treatment groups for these values. The outcome of treatment with DpTRHP was excellent, as was that of PpPD, in terms of the frequency of early gastric stasis, the duration of hospital stay, the patient's capacity for taking food, gaining weight, and working, and the performance status 6 months postoperatively. Thus, DpTRHP, which entails the least extent of resection of the head of the pancreas compared to other currently employed procedures and enables the operator to accomplish reconstruction of the pancreatic and biliary systems without resecting or interrupting the continuity of the digestive tract, was not attended by any serious complications, while, digestive tract function was well preserved, and satisfactory results were produced.     

Esophagoplasty with the colon in flap patients with burn strictures of the esophagus

Results of coloesophagoplasty in 366 patients with long burn strictures of the esophagus are presented. The lesion was total in 74 (21.2%) of them. Inefficacy of bougieurage was indication for plastic surgery in 133 (36.3%) patients, complete obliteration of esophagus--in 53 (14.5%). Left half of the colon was used in 296 (80.9%) cases, transverse colon--in 48 (13.1%), right half of the colon--in 22 (6.0%) cases. Retrosternal shunting esophagoplasty was performed in 247 (67.5%) patients. Complications were in 84 (34.0%), necrosis of the transplant--in 4 (1.6%) patients. Extirpation of the esophagus with posteriormediastinoplasty was performed in 16 (4.4%) patients, in 14 of them--transhiatally. Complications occurred in 7 patients coloesophagopharyngoplasty was carried out in 52 (14.2%) patients with combined stricture of the esophagus and the pharynx, in 23 of them--simultaneously. Complications were in 28 (53.8%) patients. Intrapleural of coloesophagoplasty was performed in 51 patients. General hospital lethality was 3.3%. Long-term results were studied in 259 patients. Good results of esophagoplasty were seen in 135 (52.1%) patients, satisfactory--in 65 (25.1%), unsatisfactory--in 59 (22.8%) patients. Dysfunction of the artificial esophagus was seen in 22.0% patients, 12.7% patients underwent repeated reconstructive surgeries.